Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 04 Apr 2022 |
10 | Annexure -1 under rule 46 | 12 Sep 2024 |
10 | Evidence Affidavit Under Rule 46 (TOP) | 12 Sep 2024 |
2 | Reply to Exam Report (MIS-R) | 15 Jun 2022 |
3 | Authorization Letter | 17 Aug 2023 |
3 | Documents in support of Show cause Hearing (SCH) | 17 Aug 2023 |
4 | Authorization Letter | 17 Aug 2023 |
4 | Documents in support of Show cause Hearing (SCH) | 17 Aug 2023 |
5 | Documents in support of Show cause Hearing (SCH) | 18 Aug 2023 |
6 | Authorization Letter | 08 Jan 2024 |
7 | TM-O(NOTICE OF OPPOSITION) | 03 May 2024 |
8 | Journal Copy | 30 May 2024 |
9 | Annexure -1 under rule 46 | 12 Sep 2024 |
9 | Evidence Affidavit Under Rule 46 (TOP) | 12 Sep 2024 |
1 | EXAMINATION REPORT | 13596357 | 04 Jun 2022 | |
2 | Hearing Notice (Show Cause) | 15692719 | 25 Jul 2023 | |
3 | Hearing Notice (Show Cause) | 16778077 | 11 Dec 2023 | |
4 | Tribunal Accepted Notice for : 5395308 | 17125382 | 6463178 | 12 Jan 2024 |
5 | Opposition Notice | 18128891 | 6723295 | 09 May 2024 |
6 | Opposition Counter Statement | 18210143 | 6736917 | 24 May 2024 |
Cdymax was applied on 04 April 2022.
Trademark application was filed by CDYMAX INDIA PHARMA.
Trademark application has been filed under following classes.
5
As per IP India, trademark application is on the following stage:
Opposed.
Listed application Id of Cdymax is 5395308.
Trademark attorney of the Cdymax is Gimmi Joseph K., Advocate.
Cdymax is a DEVICE as per IP India data.